Comparing the efficacy of different dexamethasone regimens for maintenance treatment of multiple myeloma in standard-risk patients non-eligible for transplantation

Table 2 Univariate Cox’s proportional hazard regression analysis of factors affecting progression-free survival

Parameters	P value	HR	95%CI
			Lower	Higher
DXM 40 mg vs 20 mg	0.171	0.649	0.350	1.205
Age, yr	0	1.214	1.150	1.283
Gender	0.821	0.930	0.497	1.740
Classification	0.303	0.336	0.042	2.678
DS stage	0.185	1.701	0.776	3.726
ISS stage	0	2.850	1.734	4.682
Platelet	0.363	1.011	0.998	1.034
t(6;14)	0.586	0.048	0	2739.308
t(11;14)	0.185	0.598	0.280	1.278
CRP	0.175	1.010	0.995	1.025
HGB	0.285	0.992	0.979	1.006
ALT	0.004	1.014	1.005	1.024
AST	0.001	1.014	1.006	1.023
ALB	0.573	1.010	0.976	1.044
GLO	0.702	0.998	0.985	1.010
A/G	0.458	0.872	0.608	1.251
LDH	0.021	1.002	1.000	1.003
Ca	0.652	0.982	0.909	1.062
P	0.907	0.980	0.701	1.37
M-protein	0.982	1.000	0.996	1.004
Cr	0.325	1.000	1.000	1.001
UA	0.169	1.001	1.000	1.002
Treatment	0.009	1.913	1.173	3.119
GTA	0.565	0.707	0.217	2.300
IFG	0.134	0.44	0.151	1.288
DM	0.034	2.343	1.068	5.141
Β-CTX	0.874	1.065	0.487	2.328
Osteoporosis	0.533	1.301	0.568	2.980
Hypertension	0.668	1.254	0.445	3.536
TG	0.716	1.156	0.529	2.525
TC	0.812	1.095	0.518	2.315
Acne	0.965	0.977	0.348	2.746
PU	0.983	0.988	0.349	2.799
Insomnia	0.949	1.029	0.427	2.479

CRP: Catabolite activator protein; HGB: Hemoglobin; UA: Urea nitrogen; Cr: Creatinine; LDH: Lactate dehydrogenase; GTA: Glucose tolerance; IFG: Impaired fasting glucose; DM: Diabetes mellitus; β-CTX: β-crosslaps; TC: Total cholesterol; TG: Triglyceride; PU: Peptic ulce.